Verastem, Inc. (VSTM)
Verastem, Inc. (VSTM) Company Bio
Verastem, Inc. focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. The company was founded in 2010 and is based in Needham, Massachusetts.
VSTM Stock Chart More Charts
VSTM Price/Volume Stats
| Current price | $3.46 |
| Prev. close | $3.38 |
| Day low | $3.26 |
| Day high | $3.48 |
| 50-day MA | $4.32 |
| 200-day MA | $6.04 |
| 52-week high | $10.35 |
| 52-week low | $2.77 |
| Volume | 2,036,947 |
| Avg. volume | 2,451,562 |
| Dividend yield | N/A |
| Market Cap | 255.32M |
VSTM Returns
| 1-mo | 0.58% |
| 3-mo | -39.19% |
| 6-mo | -58.36% |
| 1-year | 13.82% |
| 3-year | 170.31% |
| 5-year | -75.89% |
| YTD | 2.98% |
| 2018 | 9.45% |
| 2017 | 174.11% |
| 2016 | -39.78% |
| 2015 | -79.65% |
| 2014 | -19.82% |
Loading social stream, please wait...